Pancreatic Necrosis

PHILADELPHIA —Higher doses of zegocractin significantly reduced severe organ failure and necrotizing pancreatitis in patients with acute pancreatitis and systemic inflammatory response syndrome, according to late-breaking data.

A new ACG guideline published in The American Journal of Gastroenterology underscored that early management “is essential” to prevent complications such as organ failure and pancreatic necrosis in patients with acute pancreatitis.